Antibodies to donor B lymphocytes and autoantibodies in renal transplantation.
A positive CDC B-lymphocyte XM is not deleterious to long-term graft outcome. A positive unfractionated CDC XM is not a contraindication to transplantation if the positive crossmatch is due entirely to anti-B-lymphocyte antibody. B-lymphocyte autoantibodies are common in hemodialysis patients, but may account for only a minority of positive B-lymphocyte XMs.
D000961:Antilymphocyte Serum / Q000032:analysis*; D001323:Autoantibodies / Q000032:analysis*; D001402:B-Lymphocytes / Q000276:immunology*; D003165:Complement System Proteins; D003601:Cytotoxicity Tests, Immunologic; D006801:Humans; D007518:Isoantibodies / Q000032:analysis*; D016030:Kidney Transplantation; D006435:Renal Dialysis; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D001323:Autoantibodies; D007518:Isoantibodies; D003165:Complement System Proteins